| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| 2413.T - M3, Inc. | HOLD | 0 @ JPY 13.6627 | JPY 0 | The current share valuation price of 2413.T based on adjusted close was JPY 13.6627. The average price that 2413.T shares were previous bought at was JPY 14.0654. The current market price is -2.9% lower than average price they were purchased at. The value of the holding in 2413.T has fallen by JPY 693 compared to the previous valuation of M3, Inc. |
| 4151.T - Kyowa Kirin Co., Ltd. | HOLD | 0 @ JPY 16.285 | JPY 0 | The current share valuation price of 4151.T based on adjusted close was JPY 16.285. The average price that 4151.T shares were previous bought at was JPY 15.9958. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in 4151.T has fallen by JPY 8,356 compared to the previous valuation of Kyowa Kirin Co., Ltd. |
| 4502.T - Takeda Pharmaceutical Company Limited | HOLD | 0 @ JPY 32.1773 | JPY 0 | The current share valuation price of 4502.T based on adjusted close was JPY 32.1773. The average price that 4502.T shares were previous bought at was JPY 29.4162. The current market price is 9.4% higher than average price they were purchased at. The value of the holding in 4502.T has fallen by JPY 9,972 compared to the previous valuation of Takeda Pharmaceutical Company Limited |
| 4503.T - Astellas Pharma Inc. | HOLD | 0 @ JPY 14.1663 | JPY 0 | The current share valuation price of 4503.T based on adjusted close was JPY 14.1663. The average price that 4503.T shares were previous bought at was JPY 11.7459. The current market price is 20.6% higher than average price they were purchased at. The value of the holding in 4503.T has increased by JPY 34,661 compared to the previous valuation of Astellas Pharma Inc. however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| 4507.T - Shionogi & Co., Ltd. | HOLD | 0 @ JPY 18.4133 | JPY 0 | The current share valuation price of 4507.T based on adjusted close was JPY 18.4133. The average price that 4507.T shares were previous bought at was JPY 17.3471. The current market price is 6.1% higher than average price they were purchased at. The value of the holding in 4507.T has fallen by JPY 4,212 compared to the previous valuation of Shionogi & Co., Ltd. |
| 4519.T - Chugai Pharmaceutical Co., Ltd. | HOLD | 0 @ JPY 53.3397 | JPY 0 | The current share valuation price of 4519.T based on adjusted close was JPY 53.3397. The average price that 4519.T shares were previous bought at was JPY 49.1108. The current market price is 8.6% higher than average price they were purchased at. The value of the holding in 4519.T has fallen by JPY 76,138 compared to the previous valuation of Chugai Pharmaceutical Co., Ltd. |
| 4523.T - Eisai Co., Ltd. | HOLD | 0 @ JPY 30.1948 | JPY 0 | The current share valuation price of 4523.T based on adjusted close was JPY 30.1948. The average price that 4523.T shares were previous bought at was JPY 30.2878. The current market price is -0.3% lower than average price they were purchased at. The value of the holding in 4523.T has fallen by JPY 13,407 compared to the previous valuation of Eisai Co., Ltd. |
| 4543.T - Terumo Corporation | HOLD | 0 @ JPY 14.3563 | JPY 0 | The current share valuation price of 4543.T based on adjusted close was JPY 14.3563. The average price that 4543.T shares were previous bought at was JPY 15.8013. The current market price is -9.1% lower than average price they were purchased at. The value of the holding in 4543.T has fallen by JPY 6,206 compared to the previous valuation of Terumo Corporation |
| 4568.T - Daiichi Sankyo Company, Limited | HOLD | 0 @ JPY 22.4355 | JPY 0 | The current share valuation price of 4568.T based on adjusted close was JPY 22.4355. The average price that 4568.T shares were previous bought at was JPY 23.3035. The current market price is -3.7% lower than average price they were purchased at. The value of the holding in 4568.T has fallen by JPY 30,768 compared to the previous valuation of Daiichi Sankyo Company, Limited |
| 4578.T - Otsuka Holdings Co., Ltd. | HOLD | 0 @ JPY 57.5772 | JPY 0 | The current share valuation price of 4578.T based on adjusted close was JPY 57.5772. The average price that 4578.T shares were previous bought at was JPY 55.3673. The current market price is 4.0% higher than average price they were purchased at. The value of the holding in 4578.T has fallen by JPY 11,701 compared to the previous valuation of Otsuka Holdings Co., Ltd. |
| 6869.T - Sysmex Corporation | HOLD | 0 @ JPY 9.98891 | JPY 0 | The current share valuation price of 6869.T based on adjusted close was JPY 9.98891. The average price that 6869.T shares were previous bought at was JPY 11.3201. The current market price is -11.8% lower than average price they were purchased at. The value of the holding in 6869.T has fallen by JPY 133 compared to the previous valuation of Sysmex Corporation |
| 7733.T - Olympus Corporation | HOLD | 0 @ JPY 13.2098 | JPY 0 | The current share valuation price of 7733.T based on adjusted close was JPY 13.2098. The average price that 7733.T shares were previous bought at was JPY 12.7666. The current market price is 3.5% higher than average price they were purchased at. The value of the holding in 7733.T has fallen by JPY 2,846 compared to the previous valuation of Olympus Corporation |
| 7741.T - HOYA Corporation | HOLD | 0 @ JPY 158.29 | JPY 0 | The current share valuation price of 7741.T based on adjusted close was JPY 158.29. The average price that 7741.T shares were previous bought at was JPY 146.64. The current market price is 7.9% higher than average price they were purchased at. The value of the holding in 7741.T has fallen by JPY 17,801 compared to the previous valuation of HOYA Corporation |
| A - Agilent Technologies Inc | HOLD | 0 @ USD 148.52 | USD 0 | The current share valuation price of A based on adjusted close was USD 148.52. The average price that A shares were previous bought at was USD 136.551. The current market price is 8.8% higher than average price they were purchased at. The value of the holding in A has increased by USD 174,708 compared to the previous valuation of Agilent Technologies Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| ABBV - AbbVie Inc | HOLD | 0 @ USD 220.08 | USD 0 | The current share valuation price of ABBV based on adjusted close was USD 220.08. The average price that ABBV shares were previous bought at was USD 211.303. The current market price is 4.2% higher than average price they were purchased at. The value of the holding in ABBV has fallen by USD 677,711 compared to the previous valuation of AbbVie Inc |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 125.92 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 125.92. The average price that ABT shares were previous bought at was USD 130.592. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in ABT has fallen by USD 26,150 compared to the previous valuation of Abbott Laboratories |
| ALC.SW - | HOLD | 0 @ CHF 79.5107 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 79.5107. The average price that ALC.SW shares were previous bought at was CHF 78.5684. The current market price is 1.2% higher than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 187,105 compared to the previous valuation of |
| ALNY - Alnylam Pharmaceuticals Inc | HOLD | 0 @ USD 398.29 | USD 0 | The current share valuation price of ALNY based on adjusted close was USD 398.29. The average price that ALNY shares were previous bought at was USD 417.765. The current market price is -4.7% lower than average price they were purchased at. The value of the holding in ALNY has fallen by USD 13,443 compared to the previous valuation of Alnylam Pharmaceuticals Inc |
| AMGN - Amgen Inc | HOLD | 0 @ USD 326.1 | USD 0 | The current share valuation price of AMGN based on adjusted close was USD 326.1. The average price that AMGN shares were previous bought at was USD 306.779. The current market price is 6.3% higher than average price they were purchased at. The value of the holding in AMGN has fallen by USD 167,819 compared to the previous valuation of Amgen Inc |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 807.42 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 807.42. The average price that ARGX.BR shares were previous bought at was EUR 847.755. The current market price is -4.8% lower than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 30,134 compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 190.757 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 190.757. The average price that AZN.L shares were previous bought at was GBP 168.793. The current market price is 13.0% higher than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 34,834 compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 21.07 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 21.07. The average price that BAX shares were previous bought at was USD 19.4889. The current market price is 8.1% higher than average price they were purchased at. The value of the holding in BAX has increased by USD 6,832 compared to the previous valuation of Baxter International Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 45.2602 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 45.2602. The average price that BAYN.DE shares were previous bought at was EUR 36.126. The current market price is 25.3% higher than average price they were purchased at. The value of the holding in BAYN.DE has fallen by EUR 19,804 compared to the previous valuation of Bayer AG |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 202.75 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 202.75. The average price that BDX shares were previous bought at was USD 188.269. The current market price is 7.7% higher than average price they were purchased at. The value of the holding in BDX has fallen by USD 16,582 compared to the previous valuation of Becton Dickinson and Company |
| BIIB - Biogen Inc | HOLD | 0 @ USD 187.62 | USD 0 | The current share valuation price of BIIB based on adjusted close was USD 187.62. The average price that BIIB shares were previous bought at was USD 174.391. The current market price is 7.6% higher than average price they were purchased at. The value of the holding in BIIB has increased by USD 16,856 compared to the previous valuation of Biogen Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 131.427 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 131.427. The average price that BIM.PA shares were previous bought at was EUR 127.42. The current market price is 3.1% higher than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 3,260 compared to the previous valuation of BioMerieux |
| BMY - Bloomsbury Publishing Plc | HOLD | 0 @ USD 55.86 | USD 0 | The current share valuation price of BMY based on adjusted close was USD 55.86. The average price that BMY shares were previous bought at was USD 48.4566. The current market price is 15.3% higher than average price they were purchased at. The value of the holding in BMY has fallen by USD 5,734 compared to the previous valuation of Bloomsbury Publishing Plc |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 97.64 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 97.64. The average price that BSX shares were previous bought at was USD 99.0794. The current market price is -1.5% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 28,502 compared to the previous valuation of Boston Scientific Corporation |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 97.64 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 97.64. The average price that BSX shares were previous bought at was USD 99.0794. The current market price is -1.5% lower than average price they were purchased at. The value of the holding in BSX has fallen by USD 28,502 compared to the previous valuation of MULSTRXSSXIMETFP |
| CAH - Cardinal Health Inc | HOLD | 0 @ USD 201.11 | USD 0 | The current share valuation price of CAH based on adjusted close was USD 201.11. The average price that CAH shares were previous bought at was USD 179.745. The current market price is 11.9% higher than average price they were purchased at. The value of the holding in CAH has fallen by USD 77,469 compared to the previous valuation of Cardinal Health Inc |
| CI - Cigna Corp | HOLD | 0 @ USD 278.95 | USD 0 | The current share valuation price of CI based on adjusted close was USD 278.95. The average price that CI shares were previous bought at was USD 285.169. The current market price is -2.2% lower than average price they were purchased at. The value of the holding in CI has fallen by USD 207,631 compared to the previous valuation of Cigna Corp |
| CNC - Concurrent Technologies Plc | HOLD | 0 @ USD 46.61 | USD 0 | The current share valuation price of CNC based on adjusted close was USD 46.61. The average price that CNC shares were previous bought at was USD 39.3064. The current market price is 18.6% higher than average price they were purchased at. The value of the holding in CNC has fallen by USD 33,170 compared to the previous valuation of Concurrent Technologies Plc |
| COH.AX - | HOLD | 0 @ AUD 175.871 | AUD 0 | The current share valuation price of COH.AX based on adjusted close was AUD 175.871. The average price that COH.AX shares were previous bought at was AUD 181.133. The current market price is -2.9% lower than average price they were purchased at. The value of the holding in COH.AX has fallen by AUD 30,235 compared to the previous valuation of |
| COLO-B.CO - | HOLD | 0 @ DKK 88.175 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 88.175. The average price that COLO-B.CO shares were previous bought at was DKK 89.822. The current market price is -1.8% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 8,597 compared to the previous valuation of however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| COO - The Cooper Companies, Inc. Common Stock | HOLD | 0 @ USD 83.45 | USD 0 | The current share valuation price of COO based on adjusted close was USD 83.45. The average price that COO shares were previous bought at was USD 76.6654. The current market price is 8.8% higher than average price they were purchased at. The value of the holding in COO has increased by USD 6,913 compared to the previous valuation of The Cooper Companies, Inc. Common Stock however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| COR - Cencora Inc. | HOLD | 0 @ USD 335.69 | USD 0 | The current share valuation price of COR based on adjusted close was USD 335.69. The average price that COR shares were previous bought at was USD 328.73. The current market price is 2.1% higher than average price they were purchased at. The value of the holding in COR has fallen by USD 2,111 compared to the previous valuation of Cencora Inc. |
| CSL.AX - | HOLD | 0 @ AUD 116.443 | AUD 0 | The current share valuation price of CSL.AX based on adjusted close was AUD 116.443. The average price that CSL.AX shares were previous bought at was AUD 119.612. The current market price is -2.6% lower than average price they were purchased at. The value of the holding in CSL.AX has fallen by AUD 12,242 compared to the previous valuation of |
| CVS - CVS Health Corp | HOLD | 0 @ USD 80.3 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 80.3. The average price that CVS shares were previous bought at was USD 72.562. The current market price is 10.7% higher than average price they were purchased at. The value of the holding in CVS has fallen by USD 25,917 compared to the previous valuation of CVS Health Corp |
| DEMANT.CO - | HOLD | 0 @ DKK 34.9273 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 34.9273. The average price that DEMANT.CO shares were previous bought at was DKK 34.9578. The current market price is -0.1% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 20,407 compared to the previous valuation of however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| DGX - Quest Diagnostics Incorporated | HOLD | 0 @ USD 174.44 | USD 0 | The current share valuation price of DGX based on adjusted close was USD 174.44. The average price that DGX shares were previous bought at was USD 179.616. The current market price is -2.9% lower than average price they were purchased at. The value of the holding in DGX has fallen by USD 8,712 compared to the previous valuation of Quest Diagnostics Incorporated |
| DHR - Danaher Corporation | HOLD | 0 @ USD 238.37 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 238.37. The average price that DHR shares were previous bought at was USD 213.124. The current market price is 11.8% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 180,275 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| DHR - Danaher Corporation | HOLD | 0 @ USD 238.37 | USD 0 | The current share valuation price of DHR based on adjusted close was USD 238.37. The average price that DHR shares were previous bought at was USD 213.124. The current market price is 11.8% higher than average price they were purchased at. The value of the holding in DHR has increased by USD 180,275 compared to the previous valuation of Danaher Corporation however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 249.466 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 249.466. The average price that DIM.PA shares were previous bought at was EUR 227.368. The current market price is 9.7% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 13,021 compared to the previous valuation of Sartorius Stedim Biotech |
| DXCM - DexCom Inc | HOLD | 0 @ USD 67.4 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 67.4. The average price that DXCM shares were previous bought at was USD 68.7983. The current market price is -2.0% lower than average price they were purchased at. The value of the holding in DXCM has fallen by USD 13,854 compared to the previous valuation of DexCom Inc |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 323.503 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 323.503. The average price that EL.PA shares were previous bought at was EUR 339.962. The current market price is -4.8% lower than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 140,877 compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 372.83 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 372.83. The average price that ELV shares were previous bought at was USD 341.595. The current market price is 9.1% higher than average price they were purchased at. The value of the holding in ELV has fallen by USD 77,276 compared to the previous valuation of Elevance Health Inc |
| ELV - Elevance Health Inc | HOLD | 0 @ USD 372.83 | USD 0 | The current share valuation price of ELV based on adjusted close was USD 372.83. The average price that ELV shares were previous bought at was USD 341.595. The current market price is 9.1% higher than average price they were purchased at. The value of the holding in ELV has fallen by USD 77,276 compared to the previous valuation of Elevance Health Inc |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 80.6489 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 80.6489. The average price that ERF.PA shares were previous bought at was EUR 70.5399. The current market price is 14.3% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 1,545 compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 85.13 | USD 0 | The current share valuation price of EW based on adjusted close was USD 85.13. The average price that EW shares were previous bought at was USD 81.3837. The current market price is 4.6% higher than average price they were purchased at. The value of the holding in EW has increased by USD 60,378 compared to the previous valuation of Edwards Lifesciences Corp however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 45.9819 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 45.9819. The average price that FME.DE shares were previous bought at was EUR 49.2589. The current market price is -6.7% lower than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 3,047 compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| FPH.NZ - | HOLD | 0 @ NZD 22.0357 | NZD 0 | The current share valuation price of FPH.NZ based on adjusted close was NZD 22.0357. The average price that FPH.NZ shares were previous bought at was NZD 21.468. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in FPH.NZ has fallen by NZD 4,817 compared to the previous valuation of |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 57.3087 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 57.3087. The average price that FRE.DE shares were previous bought at was EUR 53.8775. The current market price is 6.4% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 7,940 compared to the previous valuation of Fresenius SE & Co KGaA |
| GALD.SW - | HOLD | 0 @ CHF 206.204 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 206.204. The average price that GALD.SW shares were previous bought at was CHF 187.997. The current market price is 9.7% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 19,266 compared to the previous valuation of however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 87.28 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 87.28. The average price that GEHC shares were previous bought at was USD 78.8449. The current market price is 10.7% higher than average price they were purchased at. The value of the holding in GEHC has fallen by USD 9,847 compared to the previous valuation of GE HealthCare Technologies Inc. |
| GILD - Guild Esports Plc | HOLD | 0 @ USD 121.1 | USD 0 | The current share valuation price of GILD based on adjusted close was USD 121.1. The average price that GILD shares were previous bought at was USD 118.833. The current market price is 1.9% higher than average price they were purchased at. The value of the holding in GILD has increased by USD 72,004 compared to the previous valuation of Guild Esports Plc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 339.926 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 339.926. The average price that GMAB.CO shares were previous bought at was DKK 294.268. The current market price is 15.5% higher than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 62,607 compared to the previous valuation of however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 13.2591 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 13.2591. The average price that GRF.MC shares were previous bought at was EUR 13.035. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in GRF.MC has fallen by EUR 2,611 compared to the previous valuation of Grifols SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 25.3073 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 25.3073. The average price that GSK.L shares were previous bought at was GBP 23.5072. The current market price is 7.7% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 26,807 compared to the previous valuation of GlaxoSmithKline PLC |
| HCA - HCA Holdings Inc | HOLD | 0 @ USD 472.07 | USD 0 | The current share valuation price of HCA based on adjusted close was USD 472.07. The average price that HCA shares were previous bought at was USD 454.869. The current market price is 3.8% higher than average price they were purchased at. The value of the holding in HCA has fallen by USD 31,602 compared to the previous valuation of HCA Holdings Inc |
| HIK.L - | HOLD | 0 @ GBP 21.1207 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 21.1207. The average price that HIK.L shares were previous bought at was GBP 22.3436. The current market price is -5.5% lower than average price they were purchased at. The value of the holding in HIK.L has increased by GBP 4,664 compared to the previous valuation of however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.9313 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.9313. The average price that HLN.L shares were previous bought at was GBP 4.9067. The current market price is 0.5% higher than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 23,857 compared to the previous valuation of Haleon PLC |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.87 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.87. The average price that HOLX shares were previous bought at was USD 71.763. The current market price is 4.3% higher than average price they were purchased at. The value of the holding in HOLX has fallen by USD 895 compared to the previous valuation of Hologic Inc |
| HUM - Hummingbird Resources PLC | HOLD | 0 @ USD 276.85 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 276.85. The average price that HUM shares were previous bought at was USD 264.768. The current market price is 4.6% higher than average price they were purchased at. The value of the holding in HUM has fallen by USD 14,458 compared to the previous valuation of Hummingbird Resources PLC |
| HUM - Humana Inc | HOLD | 0 @ USD 276.85 | USD 0 | The current share valuation price of HUM based on adjusted close was USD 276.85. The average price that HUM shares were previous bought at was USD 264.768. The current market price is 4.6% higher than average price they were purchased at. The value of the holding in HUM has fallen by USD 14,458 compared to the previous valuation of Humana Inc |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 713.35 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 713.35. The average price that IDXX shares were previous bought at was USD 645.031. The current market price is 10.6% higher than average price they were purchased at. The value of the holding in IDXX has increased by USD 16,698 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| ILMN - Illumina Inc | HOLD | 0 @ USD 141.07 | USD 0 | The current share valuation price of ILMN based on adjusted close was USD 141.07. The average price that ILMN shares were previous bought at was USD 117.077. The current market price is 20.5% higher than average price they were purchased at. The value of the holding in ILMN has fallen by USD 17,740 compared to the previous valuation of Illumina Inc |
| INCY - Incyte Corporation | HOLD | 0 @ USD 106.87 | USD 0 | The current share valuation price of INCY based on adjusted close was USD 106.87. The average price that INCY shares were previous bought at was USD 103.079. The current market price is 3.7% higher than average price they were purchased at. The value of the holding in INCY has increased by USD 13,506 compared to the previous valuation of Incyte Corporation however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| INSM - Insmed Inc | HOLD | 0 @ USD 175.97 | USD 0 | The current share valuation price of INSM based on adjusted close was USD 175.97. The average price that INSM shares were previous bought at was USD 186.567. The current market price is -5.7% lower than average price they were purchased at. The value of the holding in INSM has increased by USD 74,328 compared to the previous valuation of Insmed Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 148.306 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 148.306. The average price that IPN.PA shares were previous bought at was EUR 137.191. The current market price is 8.1% higher than average price they were purchased at. The value of the holding in IPN.PA has increased by EUR 1,210 compared to the previous valuation of Ipsen SA however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| IQV - IQVIA Holdings Inc | HOLD | 0 @ USD 242.41 | USD 0 | The current share valuation price of IQV based on adjusted close was USD 242.41. The average price that IQV shares were previous bought at was USD 207.407. The current market price is 16.9% higher than average price they were purchased at. The value of the holding in IQV has fallen by USD 36,916 compared to the previous valuation of IQVIA Holdings Inc |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 586.24 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 586.24. The average price that ISRG shares were previous bought at was USD 543.235. The current market price is 7.9% higher than average price they were purchased at. The value of the holding in ISRG has increased by USD 32,546 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| JNJ - Johnson & Johnson | HOLD | 0 @ USD 204.39 | USD 0 | The current share valuation price of JNJ based on adjusted close was USD 204.39. The average price that JNJ shares were previous bought at was USD 175.6. The current market price is 16.4% higher than average price they were purchased at. The value of the holding in JNJ has fallen by USD 236,685 compared to the previous valuation of Johnson & Johnson |
| LH - Laboratory Corporation of America Holdings | HOLD | 0 @ USD 251.81 | USD 0 | The current share valuation price of LH based on adjusted close was USD 251.81. The average price that LH shares were previous bought at was USD 259.802. The current market price is -3.1% lower than average price they were purchased at. The value of the holding in LH has fallen by USD 5,763 compared to the previous valuation of Laboratory Corporation of America Holdings |
| LLY - Eli Lilly and Company | HOLD | 0 @ USD 1063.56 | USD 0 | The current share valuation price of LLY based on adjusted close was USD 1063.56. The average price that LLY shares were previous bought at was USD 909.26. The current market price is 17.0% higher than average price they were purchased at. The value of the holding in LLY has fallen by USD 1,636,894 compared to the previous valuation of Eli Lilly and Company |
| LONN.SW - | HOLD | 0 @ CHF 691.007 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 691.007. The average price that LONN.SW shares were previous bought at was CHF 674.917. The current market price is 2.4% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 277 compared to the previous valuation of |
| MCK - McKesson Corporation | HOLD | 0 @ USD 816.06 | USD 0 | The current share valuation price of MCK based on adjusted close was USD 816.06. The average price that MCK shares were previous bought at was USD 795.576. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in MCK has increased by USD 25,617 compared to the previous valuation of McKesson Corporation however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 97.53 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 97.53. The average price that MDT shares were previous bought at was USD 97.5051. The current market price is 0.0% higher than average price they were purchased at. The value of the holding in MDT has fallen by USD 45,356 compared to the previous valuation of Medtronic PLC |
| MRK - Marks Electrical Group PLC | HOLD | 0 @ USD 110.53 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 110.53. The average price that MRK shares were previous bought at was USD 87.2473. The current market price is 26.7% higher than average price they were purchased at. The value of the holding in MRK has fallen by USD 92,253 compared to the previous valuation of Marks Electrical Group PLC |
| MRK - Merck & Company Inc | HOLD | 0 @ USD 110.53 | USD 0 | The current share valuation price of MRK based on adjusted close was USD 110.53. The average price that MRK shares were previous bought at was USD 87.2473. The current market price is 26.7% higher than average price they were purchased at. The value of the holding in MRK has fallen by USD 92,253 compared to the previous valuation of Merck & Company Inc |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 149.354 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 149.354. The average price that MRK.DE shares were previous bought at was EUR 135.844. The current market price is 9.9% higher than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 1,151 compared to the previous valuation of Merck KGaA however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| MTD - Mettler-Toledo International Inc | HOLD | 0 @ USD 1485.12 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1485.12. The average price that MTD shares were previous bought at was USD 1456.46. The current market price is 2.0% higher than average price they were purchased at. The value of the holding in MTD has increased by USD 53,345 compared to the previous valuation of Mettler-Toledo International Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| MTD - AMUNDI EUR GOV 710 | HOLD | 0 @ USD 1485.12 | USD 0 | The current share valuation price of MTD based on adjusted close was USD 1485.12. The average price that MTD shares were previous bought at was USD 1456.46. The current market price is 2.0% higher than average price they were purchased at. The value of the holding in MTD has increased by USD 53,345 compared to the previous valuation of AMUNDI EUR GOV 710 however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| NBIX - Neurocrine Biosciences Inc | HOLD | 0 @ USD 135.79 | USD 0 | The current share valuation price of NBIX based on adjusted close was USD 135.79. The average price that NBIX shares were previous bought at was USD 142.85. The current market price is -4.9% lower than average price they were purchased at. The value of the holding in NBIX has increased by USD 488 compared to the previous valuation of Neurocrine Biosciences Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 142.345 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 142.345. The average price that NOVN.SW shares were previous bought at was CHF 129.508. The current market price is 9.9% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 26,931 compared to the previous valuation of |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 59.4247 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 59.4247. The average price that NOVO-B.CO shares were previous bought at was DKK 53.8635. The current market price is 10.3% higher than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 545,734 compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| NTRA - Natera Inc | HOLD | 0 @ USD 234.31 | USD 0 | The current share valuation price of NTRA based on adjusted close was USD 234.31. The average price that NTRA shares were previous bought at was USD 191.37. The current market price is 22.4% higher than average price they were purchased at. The value of the holding in NTRA has fallen by USD 19,062 compared to the previous valuation of Natera Inc |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 76.7723 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 76.7723. The average price that ORNBV.HE shares were previous bought at was EUR 69.7537. The current market price is 10.1% higher than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 3,120 compared to the previous valuation of Orion Oyj |
| PFE - Pfizer Inc | HOLD | 0 @ USD 25.48 | USD 0 | The current share valuation price of PFE based on adjusted close was USD 25.48. The average price that PFE shares were previous bought at was USD 24.8767. The current market price is 2.4% higher than average price they were purchased at. The value of the holding in PFE has increased by USD 55,730 compared to the previous valuation of Pfizer Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 29.6031 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 29.6031. The average price that PHIA.AS shares were previous bought at was EUR 26.8187. The current market price is 10.4% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 1,933 compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| PME.AX - | HOLD | 0 @ AUD 140.442 | AUD 0 | The current share valuation price of PME.AX based on adjusted close was AUD 140.442. The average price that PME.AX shares were previous bought at was AUD 167.924. The current market price is -16.4% lower than average price they were purchased at. The value of the holding in PME.AX has fallen by AUD 7,425 compared to the previous valuation of |
| PODD - Insulet Corporation | HOLD | 0 @ USD 289.04 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 289.04. The average price that PODD shares were previous bought at was USD 324.529. The current market price is -10.9% lower than average price they were purchased at. The value of the holding in PODD has fallen by USD 13,355 compared to the previous valuation of Insulet Corporation |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 57.7161 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 57.7161. The average price that REC.MI shares were previous bought at was EUR 57.943. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 1,134 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| REGN - Regeneron Pharmaceuticals Inc | HOLD | 0 @ USD 796.55 | USD 0 | The current share valuation price of REGN based on adjusted close was USD 796.55. The average price that REGN shares were previous bought at was USD 722.02. The current market price is 10.3% higher than average price they were purchased at. The value of the holding in REGN has fallen by USD 34,895 compared to the previous valuation of Regeneron Pharmaceuticals Inc |
| RMD - ResMed Inc | HOLD | 0 @ USD 252.47 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 252.47. The average price that RMD shares were previous bought at was USD 253.384. The current market price is -0.4% lower than average price they were purchased at. The value of the holding in RMD has increased by USD 7,386 compared to the previous valuation of ResMed Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 435.374 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 435.374. The average price that RO.SW shares were previous bought at was CHF 353.055. The current market price is 23.3% higher than average price they were purchased at. The value of the holding in RO.SW has increased by CHF 22,183 compared to the previous valuation of however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 425.388 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 425.388. The average price that ROG.SW shares were previous bought at was CHF 368.007. The current market price is 15.6% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 22,016 compared to the previous valuation of however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| RPRX - Royalty Pharma Plc | HOLD | 0 @ USD 40.17 | USD 0 | The current share valuation price of RPRX based on adjusted close was USD 40.17. The average price that RPRX shares were previous bought at was USD 37.8452. The current market price is 6.1% higher than average price they were purchased at. The value of the holding in RPRX has fallen by USD 882 compared to the previous valuation of Royalty Pharma Plc |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 98.2966 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 98.2966. The average price that SAN.PA shares were previous bought at was EUR 98.5223. The current market price is -0.2% lower than average price they were purchased at. The value of the holding in SAN.PA has increased by EUR 100,315 compared to the previous valuation of Sanofi SA however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| SDZ.SW - | HOLD | 0 @ CHF 75.5914 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 75.5914. The average price that SDZ.SW shares were previous bought at was CHF 62.8878. The current market price is 20.2% higher than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 2,102 compared to the previous valuation of |
| SHL.AX - | HOLD | 0 @ AUD 14.9655 | AUD 0 | The current share valuation price of SHL.AX based on adjusted close was AUD 14.9655. The average price that SHL.AX shares were previous bought at was AUD 15.0911. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in SHL.AX has increased by AUD 187 compared to the previous valuation of however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 54.1423 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 54.1423. The average price that SHL.DE shares were previous bought at was EUR 53.0801. The current market price is 2.0% higher than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 1,185 compared to the previous valuation of Siemens Healthineers AG |
| SIG.AX - | HOLD | 0 @ AUD 1.93081 | AUD 0 | The current share valuation price of SIG.AX based on adjusted close was AUD 1.93081. The average price that SIG.AX shares were previous bought at was AUD 1.90641. The current market price is 1.3% higher than average price they were purchased at. The value of the holding in SIG.AX has increased by AUD 1,253 compared to the previous valuation of however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 16.8805 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 16.8805. The average price that SN.L shares were previous bought at was GBP 16.9338. The current market price is -0.3% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 3,622 compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 37.766 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 37.766. The average price that SOBI.ST shares were previous bought at was SEK 33.5896. The current market price is 12.4% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 3,026 compared to the previous valuation of however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| SOLV - Solventum Corp. | HOLD | 0 @ USD 86.14 | USD 0 | The current share valuation price of SOLV based on adjusted close was USD 86.14. The average price that SOLV shares were previous bought at was USD 75.3484. The current market price is 14.3% higher than average price they were purchased at. The value of the holding in SOLV has increased by USD 1,689 compared to the previous valuation of Solventum Corp. however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 264.12 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 264.12. The average price that SOON.SW shares were previous bought at was CHF 268.708. The current market price is -1.7% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 10,591 compared to the previous valuation of |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 299.523 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 299.523. The average price that SRT3.DE shares were previous bought at was EUR 266.736. The current market price is 12.3% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 76,858 compared to the previous valuation of Sartorius AG |
| STE - STERIS plc | HOLD | 0 @ USD 256.82 | USD 0 | The current share valuation price of STE based on adjusted close was USD 256.82. The average price that STE shares were previous bought at was USD 247.158. The current market price is 3.9% higher than average price they were purchased at. The value of the holding in STE has fallen by USD 146,668 compared to the previous valuation of STERIS plc |
| STMN.SW - | HOLD | 0 @ CHF 125.133 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 125.133. The average price that STMN.SW shares were previous bought at was CHF 121.066. The current market price is 3.4% higher than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 609 compared to the previous valuation of |
| SYK - Stryker Corporation | HOLD | 0 @ USD 367.54 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 367.54. The average price that SYK shares were previous bought at was USD 367.214. The current market price is 0.1% higher than average price they were purchased at. The value of the holding in SYK has increased by USD 6,018 compared to the previous valuation of Stryker Corporation however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| TEVA - Teva Pharma Industries Ltd ADR | HOLD | 0 @ USD 32.01 | USD 0 | The current share valuation price of TEVA based on adjusted close was USD 32.01. The average price that TEVA shares were previous bought at was USD 22.8569. The current market price is 40.0% higher than average price they were purchased at. The value of the holding in TEVA has fallen by USD 13,646 compared to the previous valuation of Teva Pharma Industries Ltd ADR |
| TMO - Time Out Group plc | HOLD | 0 @ USD 618.86 | USD 0 | The current share valuation price of TMO based on adjusted close was USD 618.86. The average price that TMO shares were previous bought at was USD 495.883. The current market price is 24.8% higher than average price they were purchased at. The value of the holding in TMO has increased by USD 308,456 compared to the previous valuation of Time Out Group plc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 296.613 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 296.613. The average price that UCB.BR shares were previous bought at was EUR 261.813. The current market price is 13.3% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 50,408 compared to the previous valuation of UCB SA however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| UNH - UnitedHealth Group Incorporated | HOLD | 0 @ USD 343.98 | USD 0 | The current share valuation price of UNH based on adjusted close was USD 343.98. The average price that UNH shares were previous bought at was USD 323.389. The current market price is 6.4% higher than average price they were purchased at. The value of the holding in UNH has fallen by USD 226,652 compared to the previous valuation of UnitedHealth Group Incorporated |
| UTHR - United Therapeutics Corporation | HOLD | 0 @ USD 483.23 | USD 0 | The current share valuation price of UTHR based on adjusted close was USD 483.23. The average price that UTHR shares were previous bought at was USD 453.419. The current market price is 6.6% higher than average price they were purchased at. The value of the holding in UTHR has fallen by USD 8,079 compared to the previous valuation of United Therapeutics Corporation |
| VEEV - Veeva Systems Inc Class A | HOLD | 0 @ USD 240.12 | USD 0 | The current share valuation price of VEEV based on adjusted close was USD 240.12. The average price that VEEV shares were previous bought at was USD 259.882. The current market price is -7.6% lower than average price they were purchased at. The value of the holding in VEEV has fallen by USD 33,235 compared to the previous valuation of Veeva Systems Inc Class A |
| VRTX - Vertex Pharmaceuticals Inc | HOLD | 0 @ USD 463.86 | USD 0 | The current share valuation price of VRTX based on adjusted close was USD 463.86. The average price that VRTX shares were previous bought at was USD 436.478. The current market price is 6.3% higher than average price they were purchased at. The value of the holding in VRTX has fallen by USD 208,094 compared to the previous valuation of Vertex Pharmaceuticals Inc |
| WAT - Waters Corporation | HOLD | 0 @ USD 396.75 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 396.75. The average price that WAT shares were previous bought at was USD 356.172. The current market price is 11.4% higher than average price they were purchased at. The value of the holding in WAT has increased by USD 1,820 compared to the previous valuation of Waters Corporation however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| WAT - MULETFWATIMETFP | HOLD | 0 @ USD 396.75 | USD 0 | The current share valuation price of WAT based on adjusted close was USD 396.75. The average price that WAT shares were previous bought at was USD 356.172. The current market price is 11.4% higher than average price they were purchased at. The value of the holding in WAT has increased by USD 1,820 compared to the previous valuation of MULETFWATIMETFP however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| WST - West Pharmaceutical Services Inc | HOLD | 0 @ USD 275.52 | USD 0 | The current share valuation price of WST based on adjusted close was USD 275.52. The average price that WST shares were previous bought at was USD 268.344. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in WST has increased by USD 517 compared to the previous valuation of West Pharmaceutical Services Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 92.8499 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 92.8499. The average price that ZBH shares were previous bought at was USD 94.7611. The current market price is -2.0% lower than average price they were purchased at. The value of the holding in ZBH has fallen by USD 6,171 compared to the previous valuation of Zimmer Biomet Holdings Inc |
| ZTS - Zoetis Inc | HOLD | 0 @ USD 127.17 | USD 0 | The current share valuation price of ZTS based on adjusted close was USD 127.17. The average price that ZTS shares were previous bought at was USD 132.994. The current market price is -4.4% lower than average price they were purchased at. The value of the holding in ZTS has increased by USD 32,067 compared to the previous valuation of Zoetis Inc however if the holding was sold on 2026-01-09 this would crystalise an overall loss. |